| Document Date: 2015-04-09 21:19:43
Open Document File Size: 1.004,62 KBShare Result on Facebook
City Tarrytown / / Company Regeneron Pharmaceuticals Inc. / AMD / / Continent North America / / Country Japan / / Event FDA Phase / / Facility VEGF complex / The terminal / / IndustryTerm machinery / mg/mL solution / / MedicalCondition photophobia / Active Intraocular Inflammation / Diabetic Retinopathy / Macular Edema / Central Retinal Vein Occlusion / spina bifida / nonfatal stroke / disease / umbilical hernia / severe intraocular inflammation / intestinal atresia / intraocular inflammation / retinal detachment / Carcinogenesis / Periocular Infections EYLEA / Active Intraocular Inflammation EYLEA / Endophthalmitis / periocular infection / gastroschisis / hernia / Branch Retinal Vein Occlusion / Periocular Infections / cleft palate / nonfatal myocardial infarction / eye pain / Diabetic Macular Edema / Age-Related Macular Degeneration / Macular Edema Following Retinal Vein Occlusion / Retinal Vein Occlusion / Retinal Detachments / Hypersensitivity / Immunogenicity Diabetic Macular Edema / Corneal edema / Hypersensitivity EYLEA / vitreous detachment / cataract / retinal tear / / OperatingSystem Microsoft Vista / / Organization DOSAGE AND ADMINISTRATION / FDA / / / Position qualified physician / Major / optic nerve head / forward / / Product Injection For Intravitreal Injection / sodium chloride / Retinal Detachments Intravitreal injections / Important Injection / Dosing / EYLEA / / ProvinceOrState New York / / PublishedMedium Baseline / / Technology Pharmacokinetics / drug metabolism / laser / antibodies / Pharmacodynamics / / URL www.fda.gov/medwatch / /
SocialTag |
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA® (aflibercept) Injection For Intra